Loading...
p90RSK Blockade Inhibits Dual BRAF and MEK Inhibitor-Resistant Melanoma by Targeting Protein Synthesis
Despite improvements in survival in metastatic melanoma with combined BRAF and mitogen-activated protein kinase/extracellular signal-regulated kinase inhibitor treatment, the overwhelming majority of patients eventually acquire resistance to both agents. Consequently, new targets for therapy in resi...
Na minha lista:
| Udgivet i: | J Invest Dermatol |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6342201/ https://ncbi.nlm.nih.gov/pubmed/28599981 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jid.2016.12.033 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|